Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Catalyst Pharmaceutical Inc. (CPRX)

Pharmaceutical Preparations

https://www.catalystpharma.com

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/08/2006

Market Cap

2,388,002,560

Shares Outstanding

107,570,000

Weighted SO

117,564,816

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

DAWN --.--%

TERN --.--%

XFOR --.--%

INZY --.--%

MREO --.--%

EXEL --.--%

TGTX --.--%

VKTX --.--%

MDGL --.--%

Beta

0.7030

Last Div

0.0000

Range

11.55-20.14

Chg

0.2100

Avg Vol

1101924

Mkt Cap

2388002560

Exch

NASDAQ

Country

US

Phone

305 420 3200

DCF Diff

16.0062

DCF

0.1238

Div Yield

0.0000

P/S

5.4963

EV Multiple

16.4518

P/FV

3.9066

Div Yield %

0.0000

P/E

34.8910

PEG

0.8083

Payout

0.0000

Current Ratio

5.1391

Quick Ratio

4.9439

Cash Ratio

4.0696

DSO

48.0299

DIO

86.1699

Op Cycle

134.1998

DPO

34.0394

CCC

100.1604

Gross Margin

0.8244

Op Margin

0.1977

Pretax Margin

0.2153

Net Margin

0.1569

Eff Tax Rate

0.2716

ROA

0.0965

ROE

0.1430

ROCE

0.1399

NI/EBT

0.7284

EBT/EBIT

1.0895

EBIT/Rev

0.1977

Debt Ratio

0.0048

D/E

0.0055

LT Debt/Cap

0.0049

Total Debt/Cap

0.0055

Int Coverage

50.3967

CF/Debt

58.3045

Equity Multi

1.1605

Rec Turnover

7.5994

Pay Turnover

10.7229

Inv Turnover

4.2358

FA Turnover

120.7546

Asset Turnover

0.6151

OCF/Share

1.6656

FCF/Share

0.6869

Cash/Share

3.1790

OCF/Sales

0.4530

FCF/OCF

0.4124

CF Coverage

58.3045

ST Coverage

511.2623

CapEx Coverage

1.7019

Div&CapEx Cov

1.7019

P/BV

3.9066

P/B

3.9066

P/S

5.4963

P/E

34.8910

P/FCF

29.4154

P/OCF

12.0801

P/CF

12.0801

PEG

0.8083

P/S

5.4963

EV Multiple

16.4518

P/FV

3.9066

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 24, 06:00 Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day The Motley Fool Jan 15, 08:45 3 Biotech Stocks You Can Buy and Hold for the Next Decade The Motley Fool Jan 15, 08:45 3 Biotech Stocks You Can Buy and Hold for the Next Decade The Motley Fool Jan 14, 08:40 Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 The Motley Fool Jan 14, 08:40 Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks GlobeNewswire Inc. Jan 04, 16:49 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. Jan 04, 16:49 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts GlobeNewswire Inc. Dec 18, 06:30 Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now The Motley Fool Nov 05, 13:15 3 Robinhood Stocks to Buy Right Now

Revenue Product Segmentation